![COMPARATIVE EFFICACY, SAFETY, TOLERABILITY, AND EFFECTIVENESS OF ANTIPSYCHOTICS IN THE TREATMENT OF DEMENTIA-RELATED PSYCHOSIS (DRP): A SYSTEMATIC LITERATURE REVIEW • The Journal of Prevention of Alzheimer's Disease COMPARATIVE EFFICACY, SAFETY, TOLERABILITY, AND EFFECTIVENESS OF ANTIPSYCHOTICS IN THE TREATMENT OF DEMENTIA-RELATED PSYCHOSIS (DRP): A SYSTEMATIC LITERATURE REVIEW • The Journal of Prevention of Alzheimer's Disease](https://www.jpreventionalzheimer.com/wp-content/uploads/2021/07/FIG-1-RAJAGO-1.gif)
COMPARATIVE EFFICACY, SAFETY, TOLERABILITY, AND EFFECTIVENESS OF ANTIPSYCHOTICS IN THE TREATMENT OF DEMENTIA-RELATED PSYCHOSIS (DRP): A SYSTEMATIC LITERATURE REVIEW • The Journal of Prevention of Alzheimer's Disease
![Frontiers | Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic Conditions Frontiers | Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic Conditions](https://www.frontiersin.org/files/Articles/644317/fneur-12-644317-HTML/image_m/fneur-12-644317-g001.jpg)
Frontiers | Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic Conditions
![Introduction - Nonpharmacologic Interventions for Agitation and Aggression in Dementia - NCBI Bookshelf Introduction - Nonpharmacologic Interventions for Agitation and Aggression in Dementia - NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/NBK356151/bin/introductionf1.jpg)
Introduction - Nonpharmacologic Interventions for Agitation and Aggression in Dementia - NCBI Bookshelf
![First FDA Approved Medication for Agitation Associated with Alzheimer's Dementia – Psychiatry Education Forum First FDA Approved Medication for Agitation Associated with Alzheimer's Dementia – Psychiatry Education Forum](https://psychiatryeducationforum.com/wp-content/uploads/2023/05/Auvelity-1.png)
First FDA Approved Medication for Agitation Associated with Alzheimer's Dementia – Psychiatry Education Forum
![Sequential drug treatment algorithm for agitation and aggression in Alzheimer's and mixed dementia - Simon JC Davies, Amer M Burhan, Donna Kim, Philip Gerretsen, Ariel Graff-Guerrero, Vincent L Woo, Sanjeev Kumar, Sarah Sequential drug treatment algorithm for agitation and aggression in Alzheimer's and mixed dementia - Simon JC Davies, Amer M Burhan, Donna Kim, Philip Gerretsen, Ariel Graff-Guerrero, Vincent L Woo, Sanjeev Kumar, Sarah](https://journals.sagepub.com/cms/10.1177/0269881117744996/asset/images/large/10.1177_0269881117744996-fig1.jpeg)
Sequential drug treatment algorithm for agitation and aggression in Alzheimer's and mixed dementia - Simon JC Davies, Amer M Burhan, Donna Kim, Philip Gerretsen, Ariel Graff-Guerrero, Vincent L Woo, Sanjeev Kumar, Sarah
![Frontiers | Antipsychotic Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD): Management of Extrapyramidal Side Effects Frontiers | Antipsychotic Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD): Management of Extrapyramidal Side Effects](https://www.frontiersin.org/files/Articles/478465/fphar-10-01045-HTML-r1/image_m/fphar-10-01045-g001.jpg)
Frontiers | Antipsychotic Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD): Management of Extrapyramidal Side Effects
![New hope for Alzheimer's dementia as prospects for disease modification fade: symptomatic treatments for agitation and psychosis | CNS Spectrums | Cambridge Core New hope for Alzheimer's dementia as prospects for disease modification fade: symptomatic treatments for agitation and psychosis | CNS Spectrums | Cambridge Core](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:20190319121907416-0503:S1092852918001360:S1092852918001360_fig1g.jpeg?pub-status=live)
New hope for Alzheimer's dementia as prospects for disease modification fade: symptomatic treatments for agitation and psychosis | CNS Spectrums | Cambridge Core
![Sequential drug treatment algorithm for agitation and aggression in Alzheimer's and mixed dementia - Simon JC Davies, Amer M Burhan, Donna Kim, Philip Gerretsen, Ariel Graff-Guerrero, Vincent L Woo, Sanjeev Kumar, Sarah Sequential drug treatment algorithm for agitation and aggression in Alzheimer's and mixed dementia - Simon JC Davies, Amer M Burhan, Donna Kim, Philip Gerretsen, Ariel Graff-Guerrero, Vincent L Woo, Sanjeev Kumar, Sarah](https://journals.sagepub.com/cms/10.1177/0269881117744996/asset/images/large/10.1177_0269881117744996-fig2.jpeg)
Sequential drug treatment algorithm for agitation and aggression in Alzheimer's and mixed dementia - Simon JC Davies, Amer M Burhan, Donna Kim, Philip Gerretsen, Ariel Graff-Guerrero, Vincent L Woo, Sanjeev Kumar, Sarah
![Guidelines for the Management of Cognitive and Behavioral Problems in Dementia | American Board of Family Medicine Guidelines for the Management of Cognitive and Behavioral Problems in Dementia | American Board of Family Medicine](https://www.jabfm.org/content/jabfp/25/3/350/F1.large.jpg)
Guidelines for the Management of Cognitive and Behavioral Problems in Dementia | American Board of Family Medicine
![Table 2 : Commonly Prescribed Drugs for Agitation and Apathy in Dementia , and Dosage Guidelines for Older Adults | Semantic Scholar Table 2 : Commonly Prescribed Drugs for Agitation and Apathy in Dementia , and Dosage Guidelines for Older Adults | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/164b83639f130601ade3b605ba9f6564bb9d8304/2-Table1-1.png)
Table 2 : Commonly Prescribed Drugs for Agitation and Apathy in Dementia , and Dosage Guidelines for Older Adults | Semantic Scholar
![Clinical and cost-effectiveness of the Managing Agitation and Raising Quality of Life (MARQUE) intervention for agitation in people with dementia in care homes: a single-blind, cluster-randomised controlled trial - The Lancet Psychiatry Clinical and cost-effectiveness of the Managing Agitation and Raising Quality of Life (MARQUE) intervention for agitation in people with dementia in care homes: a single-blind, cluster-randomised controlled trial - The Lancet Psychiatry](https://www.thelancet.com/cms/asset/69db006f-30a4-453c-b8a4-ea37e37ca33e/gr1.gif)
Clinical and cost-effectiveness of the Managing Agitation and Raising Quality of Life (MARQUE) intervention for agitation in people with dementia in care homes: a single-blind, cluster-randomised controlled trial - The Lancet Psychiatry
![Pain and agitation treatment in severe dementia patients: The need for Italian Mobilization–Observation–Behavior–Intensity–Dementia (I-MOBID2) pain scale translation, adaptation and validation with psychometric testing - ScienceDirect Pain and agitation treatment in severe dementia patients: The need for Italian Mobilization–Observation–Behavior–Intensity–Dementia (I-MOBID2) pain scale translation, adaptation and validation with psychometric testing - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0753332222004024-ga1.jpg)